CLASS III Drug recall · Reported 21 Jul 2021 · FDA Enforcement Report

B-Force, Homeopathic recalled by Grato Holdings

Grato Holdings is recalling B-Force, Homeopathic, distributed in Florida. The recall was initiated on 18 Jun 2021 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot: Z61917
NDC43857-0576
Quantity recalled1480 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0653-2021
FDA event ID
88182
Recalling firm
Grato Holdings, Woodbine, IA
Brand
B Force
Manufacturer
BioActive Nutritional, Inc.
Classification
Class III
Status
Terminated
Recall initiated
18 Jun 2021
FDA classified
12 Jul 2021
Reported
21 Jul 2021
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

18 Jun 2021Recall initiated by company
12 Jul 2021Classified by FDA+24 days
21 Jul 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

B-Force, Homeopathic, 1 Fl Oz (30 mL) bottle, Distributed by: BioActive Nutritional, Inc., Melbourne, FL 32935, NDC 43857-0576-1

Where it was distributed

FL

Florida

Questions about this recall

Why was it recalled?

Superpotent

Which lots are affected?

Lot: Z61917

Where was it sold?

FL

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 30 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Grato Holdings

All 20